Clinical EffectsSeveral studies have evaluated Eylea for wet macular degeneration treatment. These studies compared Eylea with ranibizumab (Lucentis®), a similar medication that is also injected into the eye. These studies showed that Eylea is approximately as effective as Lucentis.
Eylea has also been studied for macular edema due to retinal vein occlusion. In these studies, more people given Eylea injections regained lost vision, compared to people given placebo injections (injections without any active ingredient).
When and How to Use ItSome general considerations to keep in mind during treatment with Eylea include the following:
- This medication is injected into the eye.
- For age-related macular degeneration, it is injected monthly for the first 12 weeks, and then once every two months thereafter.
- For macular edema caused by retinal vein occlusion, it is injected once a month.
- Your eye(s) will be cleansed to prevent infection, and your eye(s) will be numbed before the injection. While you should feel no pain, you may feel a little pressure.
- For Eylea to work properly, it must be used as prescribed.
The recommended dosage varies, depending on the condition being treated. Do not intentionally adjust the frequency of your doses by missing appointments or scheduling them too soon, unless your healthcare provider specifically tells you to do so.
(Click Eylea Dosage for more information.)